BioCentury
ARTICLE | Financial News

Catabasis raises $32.4 million series B

November 16, 2013 2:25 AM UTC

Catabasis Pharmaceuticals Inc. (Cambridge, Mass.) raised $32.4 million in a series B round led by new investor Lightstone Ventures. An undisclosed public crossover fund also participated, along with e...